TY  - GEN
AU  - Tauber,Shachar
AU  - Cupp,Gale
AU  - Garber,Richard
AU  - Bartell,John
AU  - Vohra,Firoz
AU  - Stroman,David
TI  - Microbiological efficacy of a new ophthalmic formulation of moxifloxacin dosed twice-daily for bacterial conjunctivitis
SN  - 1865-8652
PY  - 2011///1207
KW  - Adolescent
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Anti-Bacterial Agents
KW  - administration & dosage
KW  - Aza Compounds
KW  - Child
KW  - Child, Preschool
KW  - Conjunctivitis, Bacterial
KW  - drug therapy
KW  - Double-Blind Method
KW  - Female
KW  - Fluoroquinolones
KW  - Haemophilus Infections
KW  - Haemophilus influenzae
KW  - drug effects
KW  - Humans
KW  - Infant
KW  - Male
KW  - Microbial Sensitivity Tests
KW  - Middle Aged
KW  - Moxifloxacin
KW  - Ophthalmic Solutions
KW  - Pneumococcal Infections
KW  - Quinolines
KW  - Staphylococcal Infections
KW  - Staphylococcus aureus
KW  - Streptococcus pneumoniae
KW  - Young Adult
N1  - Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1007/s12325-011-0037-x
ER  -